7352DMT63Poster-Disease-modifying TherapySilvia Delgado Archives - 2021 CMSC Annual Meeting

2021 CMSC Annual Meeting

Tag: 7352DMT63Poster-Disease-modifying TherapySilvia Delgado

Poster-Disease-modifying Therapy

October 25, 2021

Comparable Ofatumumab Treatment Outcomes in Patients across Racial/Ethnic Groups in the Asclepios I/II and Apolitos Studies

Background: Ofatumumab is a fully human anti-CD20 monoclonal antibody approved by the FDA for treatment of adults with relapsing multiple...

Read More →

MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US

© 2021 CMSC